Spectroscopic detection of traumatic brain injury severity and biochemistry from the retina.
Carl BanburyIain B StylesNeil EisensteinElisa R ZanierGloria VeglianteAntonio BelliAnn LoganPola Goldberg OppenheimerPublished in: Biomedical optics express (2020)
Traumatic brain injury (TBI) is a major burden on healthcare services worldwide, where scientific and clinical innovation is needed to provide better understanding of biochemical damage to improve both pre-hospital assessment and intensive care monitoring. Here, we present an unconventional concept of using Raman spectroscopy to measure the biochemical response to the retina in an ex-vivo murine model of TBI. Through comparison to spectra from the brain and retina following injury, we elicit subtle spectral changes through the use of multivariate analysis, linked to a decrease in cardiolipin and indicating metabolic disruption. The ability to classify injury severity via spectra of the retina is demonstrated for severe TBI (82.0 %), moderate TBI (75.1 %) and sham groups (69.4 %). By showing that optical spectroscopy can be used to explore the eye as the window to the brain, we lay the groundwork for further exploitation of Raman spectroscopy for indirect, non-invasive assessment of brain chemistry.
Keyphrases
- traumatic brain injury
- raman spectroscopy
- healthcare
- diabetic retinopathy
- resting state
- optic nerve
- white matter
- severe traumatic brain injury
- functional connectivity
- high resolution
- cerebral ischemia
- molecular docking
- primary care
- density functional theory
- emergency department
- computed tomography
- early onset
- molecular dynamics
- risk factors
- clinical trial
- mass spectrometry
- high speed
- acute care
- double blind
- health insurance
- molecular dynamics simulations